NXPL
NextPlat Corp
$7.31
+0.17 (+2.38%)
At close · Jul 8
Market Cap
$18.23M
Shares
2,708,507
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$54.32M
-17.8%
FY2025
Net Income
-$10.46M
+25.4%
FY2025
Gross Margin
20.08%
-5.7pp
FY2025
Operating Margin
-16.57%
+18.3pp
FY2025
Diluted EPS
-$4.40
+32.3%
FY2025
Operating Cash Flow
-$6.13M
-12.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $50.25M | $54.32M | $66.08M | $37.76M | $11.71M | $7.74M | $5.69M | $5.87M | $5.73M | $6M | $4.7M | $3.95M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $6069 | — | -$120.58K | -$127.48K | -$658.16K | -$439.79K | |
| $38.8M | $43.42M | $49.07M | $26.45M | $9.22M | $5.88M | $4.46M | $4.65M | $4.69M | $4.85M | $3.62M | $2.97M | $1.74M | — | — | — | — | |
| $11.45M | $10.91M | $17.01M | $11.31M | $2.49M | $1.86M | $1.23M | $1.22M | $1.03M | $1.15M | $1.08M | $984.48K | $681.26K | — | — | — | — | |
| — | 20.08% | 25.74% | 29.96% | 21.26% | 24.03% | 21.54% | 20.84% | 18.07% | 19.16% | 22.88% | 24.92% | — | — | — | — | — | |
| — | — | — | — | — | $0 | $0 | — | $0 | $0 | $0 | $50K | $0 | — | — | — | — | |
| $800.92K | — | — | — | — | — | — | — | — | — | — | $644.87K | $401.11K | $573.79K | $98.55K | $341.23K | $333.61K | |
| $6.01M | $6.04M | $6.18M | $9.91M | $5.09M | $5.13M | $694.36K | $761.24K | $664.82K | $583.9K | $566.19K | $517.27K | — | — | — | — | — | |
| $101K | $102K | $1.71M | $1.34M | $25K | $25K | $25K | $25K | $25K | $25K | $25K | $25K | — | — | — | — | $381 | |
| — | $540K | $788K | $2.11M | $490K | $317.1K | $294.93K | $275.33K | $263.86K | $259.39K | $266.8K | $154K | $20.6K | — | — | — | — | |
| $19.47M | $19.91M | $40.03M | $34.54M | $9.69M | $8.48M | $3.26M | $2.33M | $2.16M | $2.71M | $2.71M | $2.98M | $667.44K | $573.79K | $4.67M | $1.94M | $4.29M | |
| -$8.02M | -$9M | -$23.03M | -$23.23M | -$7.2M | -$6.62M | -$2.03M | -$1.11M | -$1.13M | -$1.58M | -$1.63M | -$1.99M | $13.82K | -$573.79K | -$4.67M | -$1.94M | -$4.29M | |
| — | -16.57% | -34.84% | -61.52% | -61.51% | -85.56% | -35.75% | -18.93% | -19.73% | -26.27% | -34.7% | -50.41% | — | — | — | — | — | |
| — | -$8.46M | -$22.24M | -$21.12M | -$6.71M | -$6.31M | -$1.74M | -$836K | -$865.77K | -$1.32M | -$1.36M | -$1.84M | $34.42K | — | — | — | — | |
| — | $64K | $81K | $79K | $24K | — | — | — | — | — | — | — | — | $33.27K | $119.15K | — | — | |
| — | $358K | $731K | $620K | $21K | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$1.64M | -$1.46M | $570K | $937K | -$132K | -$1.49M | -$729.5K | $267.68K | $56.54K | $2.36M | $959.4K | $72.89K | $7325 | $1.2M | -$140.87K | -$6.78M | -$6.19M | |
| — | — | $0 | -$1.44M | -$1.74M | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$9.66M | -$10.46M | -$22.46M | -$12.38M | -$9.07M | -$8.11M | -$2.76M | -$1.38M | -$1.19M | -$3.92M | -$2.59M | -$2.06M | $6490 | $624.12K | -$7.65M | -$8.72M | -$10.48M | |
| -$9000 | $0 | $71K | $28K | $87K | — | — | $747 | $8534 | $23.46K | — | — | — | — | — | — | — | |
| -$9.64M | -$10.46M | -$14.03M | -$3.78M | -$9.16M | -$8.11M | -$2.76M | -$1.38M | -$1.19M | -$3.94M | -$2.59M | -$2.06M | $6490 | $624.12K | -$4.81M | -$8.72M | -$11.58M | |
| — | -19.26% | -21.22% | -10.01% | -78.23% | -104.75% | -48.57% | -23.51% | -20.86% | -65.6% | -55.12% | -52.25% | — | — | — | — | — | |
| -$14K | $0 | -$9.1M | -$8.63M | $0 | — | — | — | — | — | — | — | — | — | $4.8M | — | — | |
| -$10.89M | -$11.71M | -$13.43M | -$3.78M | -$9.16M | — | -$2.76M | -$1.18M | — | -$3.91M | -$2.61M | -$2.08M | $5641 | $624.12K | — | — | — | |
| -$9.67M | -$10.52M | -$22.53M | -$12.43M | -$9.2M | -$8.06M | -$2.8M | -$1.38M | -$1.2M | -$3.91M | — | — | — | — | — | — | — | |
| USD/shares | — | -$4.40 | -$6.50 | -$2.20 | -$9.60 | -$19.80 | — | — | — | -$81.00 | -$114.20 | -$2.60 | $0.00 | $3.80 | — | — | — |
| USD/shares | — | -$4.40 | -$6.50 | -$2.20 | -$9.60 | — | — | — | — | -$81.00 | -$114.20 | -$2.60 | $0.00 | $3.60 | — | — | — |
| shares | — | 2.65M | 2.06M | 1.75M | 959.2K | 408.08K | 2123.5 | 10.62K | 6243.5 | 48.25K | 22.85K | 799.41K | 254K | 166.13K | 24.93M | 22.01M | — |
| shares | — | 2.65M | 2.06M | 1.75M | 959.2K | 408.08K | 2123.5 | 10.62K | 6243.5 | 48.25K | 22.85K | 799.41K | 9M | 171.46K | 24.93M | 22.01M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2025: $100K in buybacks, $133.27K in dividends.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Healthcare Operations | $39,714,000 | $52,291,000 | $26,779,000 | $0 |
| Ecommerce | $14,608,000 | $13,791,000 | $10,977,000 | $11,710,000 |
| Ecommerce Revenue | $14,608,000 | $13,791,000 | $10,977,000 | $11,710,000 |
By Geography (USD)
| Component | 2021-12-31 | 2020-12-31 |
|---|---|---|
| Europe | $5,146,336 | $3,658,612 |
| North America | $1,776,288 | $1,532,273 |
| Asia Pacific | $695,770 | $420,048 |
| Africa | $84,377 | $43,948 |
| South America | $37,139 | $34,915 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Pharmacy Prescription and Other Revenue Net of PBM Fees | $35,704,000 | $41,907,000 | $21,412,000 | $0 |
| Ecommerce Revenue | $14,608,000 | $13,791,000 | $10,977,000 | $11,710,000 |
| Pharmacy 340B Contract | $4,010,000 | $10,384,000 | $5,367,000 | $0 |
| Ecommerce | — | $13,791,000 | $10,977,000 | $11,710,000 |
| Pharmacy Prescription Other Revenue and Ecommerce | — | $55,099,000 | $32,389,000 | $11,710,000 |
| Product | — | $55,540,000 | $32,389,000 | $11,710,000 |
| Service | — | $10,542,000 | $5,367,000 | $0 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Ecommerce | -$4,396,000 | -$6,510,000 | -$8,690,000 | -$7,203,000 |
| Healthcare Operations | -$4,604,000 | -$16,755,000 | -$14,658,000 | $0 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Healthcare Operations | -11.6% | -32% | -54.7% | — |
| Ecommerce | -30.1% | -47.2% | -79.2% | -61.5% |